Abstract

Niflumic acid (NFA), 2-(α,α,α-trifluoro-m-toluidino) nicotinic acid, is a potent analgesic and anti-inflammatory drug, and its prodrug, talniflumate, 3-phthalidyl ester of 2([3-(trifluoromethyl)phenyl]amino)-3-pyridinecarboxylic acid, has been widely used for the treatment of rheumatoid diseases. 1 Talniflumate, which is synthesized by esterification of the carboxyl group of NFA, exerts its activity in the body through its conversion to NFA by esterase. It has been reported to show lower ulcerogenic side effects and greater anti-inflammatory activity than the NFA. 2 Several methods for the determination of NFA in biological fluids have been published, including luminescence, 3 gas chromatography, 4 and high-performance liquid chromatography (HPLC). 5-10 Among them, some sensitive HPLC

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.